181 related articles for article (PubMed ID: 23362272)
1. Soluble epoxide hydrolase dimerization is required for hydrolase activity.
Nelson JW; Subrahmanyan RM; Summers SA; Xiao X; Alkayed NJ
J Biol Chem; 2013 Mar; 288(11):7697-7703. PubMed ID: 23362272
[TBL] [Abstract][Full Text] [Related]
2. Disrupting Dimerization Translocates Soluble Epoxide Hydrolase to Peroxisomes.
Nelson JW; Das AJ; Barnes AP; Alkayed NJ
PLoS One; 2016; 11(5):e0152742. PubMed ID: 27203283
[TBL] [Abstract][Full Text] [Related]
3. Effect of soluble epoxide hydrolase polymorphism on substrate and inhibitor selectivity and dimer formation.
Morisseau C; Wecksler AT; Deng C; Dong H; Yang J; Lee KS; Kodani SD; Hammock BD
J Lipid Res; 2014 Jun; 55(6):1131-8. PubMed ID: 24771868
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.
Koerner IP; Jacks R; DeBarber AE; Koop D; Mao P; Grant DF; Alkayed NJ
J Neurosci; 2007 Apr; 27(17):4642-9. PubMed ID: 17460077
[TBL] [Abstract][Full Text] [Related]
5. Development of a high throughput cell-based assay for soluble epoxide hydrolase using BacMam technology.
Xie W; Tang X; Lu Q; Ames RS; Ratcliffe SJ; Li H
Mol Biotechnol; 2010 Jul; 45(3):207-17. PubMed ID: 20339956
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase.
Widstrom RL; Norris AW; Van Der Veer J; Spector AA
Biochemistry; 2003 Oct; 42(40):11762-7. PubMed ID: 14529287
[TBL] [Abstract][Full Text] [Related]
7. Phosphatase activity of soluble epoxide hydrolase.
Kramer J; Proschak E
Prostaglandins Other Lipid Mediat; 2017 Nov; 133():88-92. PubMed ID: 28729091
[TBL] [Abstract][Full Text] [Related]
8. Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia.
Zhang W; Iliff JJ; Campbell CJ; Wang RK; Hurn PD; Alkayed NJ
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1475-81. PubMed ID: 19471280
[TBL] [Abstract][Full Text] [Related]
9. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
Das Mahapatra A; Choubey R; Datta B
Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of Xenopus soluble epoxide hydrolase.
Purba ER; Oguro A; Imaoka S
Biochim Biophys Acta; 2014 Jul; 1841(7):954-62. PubMed ID: 24681163
[TBL] [Abstract][Full Text] [Related]
11. Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis.
Enayetallah AE; Grant DF
Biochem Biophys Res Commun; 2006 Mar; 341(1):254-60. PubMed ID: 16414022
[TBL] [Abstract][Full Text] [Related]
12. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
[TBL] [Abstract][Full Text] [Related]
13. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase.
Hou HH; Hammock BD; Su KH; Morisseau C; Kou YR; Imaoka S; Oguro A; Shyue SK; Zhao JF; Lee TS
Cardiovasc Res; 2012 Jan; 93(1):120-9. PubMed ID: 22072631
[TBL] [Abstract][Full Text] [Related]
14. The metabolism of lysophosphatidic acids by allelic variants of human soluble epoxide hydrolase.
Purba ER; Leuhery EA; Oguro A; Imaoka S
Drug Metab Pharmacokinet; 2015 Feb; 30(1):75-81. PubMed ID: 25760533
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.
Zhang D; Xie X; Chen Y; Hammock BD; Kong W; Zhu Y
Circ Res; 2012 Mar; 110(6):808-17. PubMed ID: 22354938
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.
Sun CP; Zhang XY; Morisseau C; Hwang SH; Zhang ZJ; Hammock BD; Ma XC
J Med Chem; 2021 Jan; 64(1):184-215. PubMed ID: 33369424
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
18. Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth.
Oguro A; Sakamoto K; Suzuki S; Imaoka S
Biol Pharm Bull; 2009 Dec; 32(12):1962-7. PubMed ID: 19952412
[TBL] [Abstract][Full Text] [Related]
19. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
Huang H; Weng J; Wang MH
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
Gurung AB; Mayengbam B; Bhattacharjee A
Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
